title: Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7.
abstract: Cancer histology influences the risk of venous thromboembolism and tissue factor (TF) is the key molecule in cancer-induced hypercoagulability. We investigated the relation between TF expression by pancreatic and breast cancer cells (BXPC3 and MCF7 respectively) and their capacity to trigger in vitro thrombin generation in normal human plasma. Flow cytometry and Western blot analysis for TF expression were performed using murine IgG1 monoclonal antibody against human TF. Real-time PCR for TFmRNA was also performed. Activity of TF expressed by cancer cells was measured with a specific chromogenic assay. Thrombin generation in PPP was assessed using calibrated automated thrombogram. Cancer cells were added to platelet poor plasma from healthy volunteers. In separate experiments cells were incubated with the anti-TF antibody at concentration that completely neutralized the activity of recombinant human TF on thrombin generation. BXPC3 cells expressed significantly higher amounts of functional TF as compared to MCF7 cells. Incubation of BXPC3 and MCF7 cells with PPP resulted in acceleration of the initiation phase of thrombin generation. BXPC3 cells manifested higher procoagulant potential than MCF7 cells. The incubation of BXPC3 or MCF7 cells with the anti-TF monoclonal antibody which resulted in reversal of their effect on thrombin generation. The present study establishes a link between the amount of TF expressed by cancer cells with their procoagulant activity. Both studied types of cancer cells trigger thrombin generation but they have different procoagulant potential. The procoagulant activity of BXPC3 and MCF7 cells is related to the amount of TF expressed. Kinetic parameters of thrombogram are the most relevant for the detection of the TF-dependent procoagulant activity of cancer cells. TF expression is one of the mechanisms by which cancer cells manifest their procoagulant potential but it is not the unique one. The present experimental model will allow the characterization the procoagulant fingerprint of cell lines from the same or different histological types of cancer.
authors.affiliation: ER2UPMC, Faculté de Médecine Pierre et Marie Curie, Université Paris VI, Hôpital Universitaire Tenon, Paris, France. grigoris.gerotziafas@tnn.aphp.fr
authors.forename: Grigoris T
authors.initials: GT
authors.lastname: Gerotziafas
authors.forename: Vassiliki
authors.initials: V
authors.lastname: Galea
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Mbemba
authors.forename: Amir
authors.initials: A
authors.lastname: Khaterchi
authors.forename: Mouna
authors.initials: M
authors.lastname: Sassi
authors.forename: Hela
authors.initials: H
authors.lastname: Baccouche
authors.forename: Claudie
authors.initials: C
authors.lastname: Prengel
authors.forename: Patrick
authors.initials: P
authors.lastname: van Dreden
authors.forename: Mohamed
authors.initials: M
authors.lastname: Hatmi
authors.forename: Jean François
authors.initials: JF
authors.lastname: Bernaudin
authors.forename: Ismail
authors.initials: I
authors.lastname: Elalamy
mesh_terms: D001943:Breast Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D045744:Cell Line, Tumor; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D061986:MCF-7 Cells; D010190:Pancreatic Neoplasms / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics; D013917:Thrombin / Q000235:genetics / Q000378:metabolism*; D013925:Thromboplastin / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism; D054556:Venous Thromboembolism / Q000235:genetics / Q000378:metabolism* / Q000473:pathology
chemical_list: D012333:RNA, Messenger; D013925:Thromboplastin; D013917:Thrombin